News

A new generation CDK4 inhibitor study for people with HR+ HER2- breast cancer
7/17/2025
A phase III clinical trial for people with HR+ HER2- breast cancer aims to extend survival and improve patients’ quality of life.
New Study: Providence whole genome sequencing program shows transformative potential for population health
7/1/2025
Published in Nature NPJ Genomic Medicine, Providence-led Geno4ME research program study highlights early detection, personalized prevention and prospect of improved care outcomes.
Cancer patients in Newberg receive a gift of comfort
6/19/2025
A generous gift of plush blankets helps comfort patients during their chemotherapy treatments at Providence Cancer Institute Newberg Clinic.
New Horizons in Immunotherapy for Cancer symposium: Collaborative cancer research
5/28/2025
Expert voices in immuno-oncology from inside and outside Providence gather for a day of thought-provoking discussion, discovery and collaboration.
Providence researchers share cancer discoveries at 2025 ASCO meeting
5/29/2025
Explore new findings in cancer immunotherapy and clinical research from Providence at ASCO 2025.
Personalized mRNA vaccine and next-gen immunotherapy: Two new cancer trials at Providence
5/29/2025
Providence Cancer Institute is enrolling patients for two new immunotherapy trials targeting muscle-invasive urothelial cancer and advanced solid tumors.
Renovations Complete at Portland’s Busiest Emergency Department
5/20/2025
A $47 million renovation of the emergency department at Providence St. Vincent Medical Center has transformed Portland’s busiest emergency department into a state-of-the-art space.
Clinical trials matter, just ask Randy
5/19/2025
When Randy was diagnosed with small cell lung cancer, he thought it was time to get his affairs in order. But a phase I clinical trial at Providence Cancer Institute gave him more time and hope.
Studies to be presented by Providence researchers at AACR annual meeting
5/13/2025
The annual AACR meeting draws the most innovative cancer researchers seeking breakthroughs in treatments.